Treeline Biosciences
153 employees
Biotech/Pharma
Series A · $1.1B
Open positions (5)
Company details
Team Size153
IndustryBiotech/Pharma
Funding
Total raised
$1.1B
Last stage
Series A
Investors
GV
Total raised
$1.1B
Last stage
Series A
Investors
Jeff Engelman
Former Global Head of Oncology at the Novartis Institutes for BioMedical Research and prior Director of Thoracic Oncology at Massachusetts General Hospital.
Josh Bilenker
Former founder and CEO of Loxo Oncology, which was acquired by Eli Lilly for ~$8 billion in 2019. Earlier roles include venture capital and Medical Officer at the FDA's Office of Oncology Drug Products.
LinkedInNo applications, no recruiter spam. Just the intro.
A few questions to make sure this role is the right shape for you. Two minutes.
I write the intro, send it to the founder, and handle the back-and-forth.
If they’re a yes, I book the chat. You show up — that’s the whole job-hunt.